Cytokines regulate hematopoietic cell growth and differentiation by inducing the expression of specific target genes. We have recently isolated a cytokine-inducible immediate-early gene, DUB-1, that encodes a deubiquitinating enzyme with growth regulatory activity. Interestingly, DUB-I is a member of a novel subfamily of deubiquitinating enzymes (called DUB proteins) that are induced by different cytokines and that mediate specific cytokine signals. During the proposed five year study period, we plan to study the cellular function of the DUB enzymes and the mechanism of cytokine specific induction.
In Specific Aim #1, we will utilize in vitro mutagenesis of the DUB-I cDNA in order to identify critical DUB-I domains required for deubiquitinating activity and growth regulatory activity. Mutant DUB-1 polypeptides will be used to identify binding proteins and potential substrate proteins.
In Specific Aim #2, we will identify critical sequence determinants of DUB-I protein stability.
In Specific Aim #3, we will generated DUB- deficient and DUB transgenic mice in order to assess the in vivo function of this protein subfamily. Finally, in Specific Aim #4, we will compare the enhancers of the DUB-I and DUB-2 gene for DNA sequences and binding proteins that determine the basis of cytokine-specific gene induction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043889-09
Application #
6164526
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Badman, David G
Project Start
1992-03-01
Project End
2002-02-28
Budget Start
2000-03-01
Budget End
2002-02-28
Support Year
9
Fiscal Year
2000
Total Cost
$230,877
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Rondinelli, Beatrice; Gogola, Ewa; YĆ¼cel, Hatice et al. (2017) EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation. Nat Cell Biol 19:1371-1378
Karras, Georgios I; Yi, Song; Sahni, Nidhi et al. (2017) HSP90 Shapes the Consequences of Human Genetic Variation. Cell 168:856-866.e12
Mouw, Kent W; Goldberg, Michael S; Konstantinopoulos, Panagiotis A et al. (2017) DNA Damage and Repair Biomarkers of Immunotherapy Response. Cancer Discov 7:675-693
Li, Heng; Lim, Kah Suan; Kim, Hyungjin et al. (2016) Allosteric Activation of Ubiquitin-Specific Proteases by ?-Propeller Proteins UAF1 and WDR20. Mol Cell 63:249-260
Zhang, Haojian; Kozono, David E; O'Connor, Kevin W et al. (2016) TGF-? Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia. Cell Stem Cell 18:668-81
Kais, Zeina; Rondinelli, Beatrice; Holmes, Amie et al. (2016) FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair. Cell Rep 15:2488-99
Bluteau, Dominique; Masliah-Planchon, Julien; Clairmont, Connor et al. (2016) Biallelic inactivation of REV7 is associated with Fanconi anemia. J Clin Invest 126:3580-4
Xie, Jenny; Kim, Hyungjin; Moreau, Lisa A et al. (2015) RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway. J Clin Invest 125:1523-32
Kim, Hyungjin; Dejsuphong, Donniphat; Adelmant, Guillaume et al. (2014) Transcriptional repressor ZBTB1 promotes chromatin remodeling and translesion DNA synthesis. Mol Cell 54:107-118
Wojtaszek, Jessica L; Wang, Su; Kim, Hyungjin et al. (2014) Ubiquitin recognition by FAAP20 expands the complex interface beyond the canonical UBZ domain. Nucleic Acids Res 42:13997-4005

Showing the most recent 10 out of 99 publications